Martín
Lazaro Quintela
Complexo Hospitalario Universitario de Vigo
Vigo, EspañaPublicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Vigo (25)
2023
-
Erratum: Personalized Precision Medicine for Health Care Professionals: Development of a Competency Framework (JMIR Medical Education (2023) 9 (e43656) DOI: 10.2196/43656)
JMIR Medical Education
-
Personalized Precision Medicine for Health Care Professionals: Development of a Competency Framework
JMIR Medical Education, Vol. 9
-
SEOM SOGUG clinical guideline for treatment of kidney cancer (2022)
Clinical and Translational Oncology, Vol. 25, Núm. 9, pp. 2732-2748
2022
-
A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial
European Journal of Cancer, Vol. 175, pp. 110-119
-
Measures to evaluate quality of care in renal cancer: results of a Delphi study in Spain
Clinical and Translational Oncology, Vol. 24, Núm. 3, pp. 495-502
-
Real-world data with afatinib in Spanish patients with treatment-naïve non-small-cell lung cancer harboring exon 19 deletions in epidermal growth factor receptor (Del19 EGFR): Clinical experience of the Galician Lung Cancer Group
Cancer Treatment and Research Communications, Vol. 33
2021
-
Preferences for Renal Cell Carcinoma Pharmacological Treatment: A Discrete Choice Experiment in Patients and Oncologists
Frontiers in Oncology, Vol. 11
-
Rethinking prognostic factors in locally advanced or metastatic urothelial carcinoma in the immune checkpoint blockade era: a multicenter retrospective study
ESMO open, Vol. 6, Núm. 2, pp. 100090
2020
-
PD-(L)1 inhibitors in combination with chemotherapy as first-line treatment for non-small-cell lung cancer: A pairwise meta-analysis
Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-13
-
SEOM clinical guideline for treatment of kidney cancer (2019)
Clinical and Translational Oncology, Vol. 22, Núm. 2, pp. 256-269
2019
-
Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer
Clinical and Translational Oncology, Vol. 21, Núm. 3, pp. 249-258
2018
-
Concurrent chemoradiation for locally advanced stage III non-small cell lung cancer with cisplatin, vinorelbine, and thoracic radiotherapy: a phase II study from the Galician Lung Cancer Group
Clinical and Translational Oncology, Vol. 20, Núm. 11, pp. 1467-1473
2017
-
Clinical management of epidermal growth factor receptor mutation-positive non-small cell lung cancer patients after progression on previous epidermal growth factor receptor tyrosine kinase inhibitors: The necessity of repeated molecular analysis
Translational Lung Cancer Research, Vol. 6, pp. S21-S34
-
New clinical trials regulation in Spain: analysis of royal decree 1090/2015
Clinical and Translational Oncology, Vol. 19, Núm. 3, pp. 291-300
-
Recent advances in genitourinary tumors: A review focused on biology and systemic treatment
Critical Reviews in Oncology/Hematology, Vol. 113, pp. 171-190
2016
-
Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study
BMC Cancer, Vol. 16, Núm. 1
-
Validation of the international metastatic renal-cell carcinoma database consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: The Spanish oncologic genitourinary group (SOGUG) SPAZO study
Annals of Oncology, Vol. 27, Núm. 4, pp. 706-711
2015
-
Erlotinib as second-line therapy for patients with advanced non-small-cell lung cancer and wild-type EGFR tumors
Journal of Analytical Oncology, Vol. 4, Núm. 3, pp. 94-101
-
Side effects of targeted therapy
Springer New York, pp. 377-416
2014
-
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): A Galician Lung Cancer Group (GGCP) study
Cancer Chemotherapy and Pharmacology, Vol. 73, Núm. 3, pp. 451-457